QM1114-DP

· Galderma

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for QM1114-DP, covering 2023-10-12 to 2024-10-21. Get the full timeline:

Most recent: Clinical Trial Update: Assess Aesthetic Improvement and Onset of QM1114-DP in Subjects With Moderate to Severe Glabellar Lines [Phase 3]